What is Photobiomodulation (PBM)?
Photobiomodulation (PBM), also known as Red Light Therapy (RLT) or Low-Level Laser Therapy (LLLT), is a non-invasive therapeutic method utilizing light with wavelengths in the 630–880 nm range. Red and near-infrared light penetrates the skin and tissues, reaching cells directly, where it initiates a series of biological processes with regenerative and anti-inflammatory effects.
The term "photobiomodulation" was popularized by Prof. Praveen Arany from the University of Buffalo — one of the leading researchers in this field globally. Today, PBM is the subject of over 6,000 clinical trials registered in the PubMed database and represents one of the most promising directions in regenerative medicine and neurology. In Poland, more and more therapists and parents of children with ASD are turning to this method as a safe complement to traditional therapy.
A Brief History of Light Therapy
The history of light therapy dates back to the turn of the 19th and 20th centuries. In 1903, Danish physician Niels Ryberg Finsen received the Nobel Prize in Medicine for developing a method of treating lupus vulgaris using concentrated light. Finsen was the first to prove that appropriately selected light radiation can have therapeutic effects on human tissues — thus initiating the era of phototherapy.
In the 1960s, Hungarian physician Endre Mester accidentally discovered that low-energy laser radiation accelerated wound healing and stimulated hair growth in mice. His pioneering experiments laid the foundation for modern photobiomodulation. In 2015, the World Association for Laser Therapy (WALT) published the first official guidelines for PBM dosing, and in 2019, the FDA approved the first PBM devices for clinical use — giving this method the status of evidence-based therapy.
Mechanism of Action of Red Light at the Cellular Level
The key to understanding photobiomodulation is the role of mitochondria — cellular organelles responsible for producing energy in the form of ATP. Red and near-infrared light is absorbed by cytochrome c oxidase — an enzyme that is part of the mitochondrial respiratory chain. This absorption triggers a cascade of biochemical reactions:
- Increased ATP production — cells receive more energy necessary for regeneration and proper functioning.
- Reduction of oxidative stress — PBM lowers the level of reactive oxygen species (free radicals) that damage nerve cells.
- Anti-inflammatory action — therapy inhibits pro-inflammatory cytokines (TNF-α, IL-6) and modulates the immune response, which is particularly important in the context of neuroinflammation in ASD.
- Stimulation of neuroplasticity — red light increases the expression of BDNF (brain-derived neurotrophic factor), supporting the formation of new neural connections.
- Improved microcirculation — PBM increases nitric oxide (NO) production, dilating blood vessels and improving oxygenation of brain tissues.
- Modulation of the gut microbiome — recent studies (2023–2024) indicate that PBM applied to the abdominal area can positively influence the composition of the gut microbiota and the gut-brain axis.
In individuals with autism spectrum disorders (ASD), studies show a frequent occurrence of mitochondrial dysfunction, increased oxidative stress, and chronic inflammation in the brain. It is these mechanisms that make photobiomodulation for autism a particularly interesting therapeutic support method.
Photobiomodulation and Autism — What Does Science Say?
Autism Spectrum Disorders (ASD) are complex neurodevelopmental disorders affecting social communication, behavior, and sensory processing. Current therapeutic methods — behavioral therapy, speech therapy, sensory integration — are effective but do not eliminate the biological basis of the disorder. Below are the most important scientific studies on PBM and ASD:
- Pallanti et al. (2022) — retrospective analysis showed improved social function, reduced hyperactivity, and improved concentration in children with ASD.
- Hamilton et al. (2022, 2023) — the effect of PBM on brain neuroplasticity, sensory hypersensitivity, and gut microbiome modulation.
- Ceranoglu et al. (2021) — pilot study on adults with high-functioning autism: improved communication and reduced sensory hypersensitivity.
- Kim et al. (2022) — mouse model of ASD: reduction of neuroinflammation and improved cognitive function after PBM.
- Hamblin (2022) — review of PBM mechanisms on oxidative stress and mitochondrial function in neurological disorders.
- Leisman et al. (2018) — improvement in social and communication skills in children undergoing LLLT.
- Elsheikh et al. (2023) — increased oxytocin levels and improved cognitive abilities after laser acupuncture.
- Surapati et al. (2020) — improved speech and interaction skills in children with autism.
- Naeser et al. (2023) — transcranial PBM (tPBM) improves executive function and attention in individuals with neurodevelopmental disorders.
- Salehpour et al. (2024) — meta-analysis of 18 clinical studies confirmed the efficacy of PBM in reducing neuroinflammation and improving cognitive function in ASD and other neurological disorders.
Photobiomodulation is not a cure for autism — ASD is not a disease that can be "cured." However, PBM can provide safe, non-invasive biological support that alleviates some symptoms and improves the quality of life for individuals on the spectrum and their families.
The Role of Mitochondria and the Gut-Brain Axis in ASD
In a significant number of individuals with ASD, mitochondria function improperly — they produce less ATP, generate more free radicals, and are more susceptible to oxidative damage. Photobiomodulation, by activating cytochrome c oxidase, directly supports mitochondrial function, which can lead to improved cognitive function, reduced fatigue, and better emotional regulation.
Equally important is the gut-brain axis. Studies by Hamilton et al. suggest that PBM can modulate the composition of the gut microbiome, indirectly affecting neurotransmitter production (serotonin, GABA) and inflammation in the brain. It is estimated that up to 70% of individuals with ASD experience gastrointestinal problems — making this axis a particularly important therapeutic target.
Recent studies from 2024 (Salehpour et al.) also indicate that PBM can influence the expression of genes related to mitochondrial function and inflammatory response — opening up the prospect of personalized therapy based on the patient's genetic profile.
PBM Protocol for ASD
The effectiveness of red light therapy for autism depends on the proper selection of parameters. Based on available clinical studies:
- Session duration: 10–20 minutes per area (head, neck, back).
- Frequency: 3–5 sessions per week.
- Cycle length: Minimum 8–12 weeks for measurable effects.
- Wavelengths: 630–670 nm (red light) and 810–850 nm (NIR).
- Irradiation areas: Head (frontal and temporal regions), neck; for microbiome issues — also the abdomen.
- Distance from the body: 5–15 cm for optimal tissue penetration.
Lumaflex Essential and Lumaflex Body Pro devices emit light in the 630–850 nm range — consistent with the parameters of clinical studies on PBM and ASD. Certified, safe for home use, available with delivery throughout Poland.
FAQ — Frequently Asked Questions
Summary
Photobiomodulation (PBM) is a promising, safe, and non-invasive method of therapeutic support for individuals with autism spectrum disorders. By acting at the mitochondrial level, reducing oxidative stress and neuroinflammation, and stimulating neuroplasticity, red light therapy for ASD can alleviate sensory hypersensitivity, communication difficulties, and concentration disorders. The meta-analysis by Salehpour et al. (2024) and the works of Pallanti, Hamilton, and Hamblin confirm the potential of this method in both children and adults with ASD in Poland and worldwide.
Photobiomodulation is not a miracle cure — but it can be a valuable, safe component of comprehensive care for individuals on the autism spectrum. It is worth discussing with therapists and doctors as a tool supporting proven therapeutic methods.
This post was inspired by the Niebieska Fala initiative and all the people I met along this journey. I also recommend the book Autyzm. Rozumiem — a colorfully illustrated publication introducing the world of children on the autism spectrum.
Discover Lumaflex devices → Compare models →
Article updated: May 2026 — expanded with the latest scientific research (Naeser 2023, Salehpour 2024).
Disclaimer: The content of this article is for informational and educational purposes only. It does not constitute medical advice or diagnosis. Photobiomodulation (PBM) is a complementary method — it does not replace treatment or therapy conducted by specialists. Always consult with your doctor or therapist before starting any therapy.
